Edwards Lifesciences Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 1,373.9 million compared to USD 1,376 million a year ago. Net income was USD 406.4 million compared to USD 489.5 million a year ago. Basic earnings per share from continuing operations was USD 0.65 compared to USD 0.79 a year ago. Diluted earnings per share from continuing operations was USD 0.65 compared to USD 0.78 a year ago.
For the six months, sales was USD 2,715.1 million compared to USD 2,592.6 million a year ago. Net income was USD 780 million compared to USD 827.7 million a year ago. Basic earnings per share from continuing operations was USD 1.26 compared to USD 1.33 a year ago. Diluted earnings per share from continuing operations was USD 1.24 compared to USD 1.31 a year ago.